STATCenter·
STAT+: GLP-1s are given an FDA warning for rare eye condition risk
The FDA warned that GLP-1 drugs carry a potential risk of a rare but serious eye condition sometimes referred to as an “eye stroke.”
Read at STAT →
Health · 1 sources covering this
STAT+: GLP-1s are given an FDA warning for rare eye condition risk
The FDA warned that GLP-1 drugs carry a potential risk of a rare but serious eye condition sometimes referred to as an “eye stroke.”
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/3114fb6ce11598e8cad606803a573b6026b4b06a" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="STAT+: GLP-1s are given an FDA warning for rare eye condition risk"></iframe>
